Table of Contents
1 Table Of Contents 2 1.1 List of Tables 7 1.2 List of Figures 9 2
Introduction 10 2.1 What Is This Report About? 10 3 Definitions of
Markets Covered in the Report 11 3.1 Ophthalmic Devices 11 3.2
Cataract Surgery 11 3.2.1 Phacoemulsification Equipment 11 3.2.2 Intra
Ocular Lens 11 3.3 Vision Care 11 3.3.1 Ophthalmoscopes 11 3.3.2
Contact lenses 11 3.3.3 Lens care 11 3.3.4 Ophthalmic lens 12
3.3.5 Rigid Gas Permeable Contact Lenses 12 3.4 Refractive Surgery 12
4 Healthcare Sector Review 13 5 Regulation System 14 5.1 Medical
Equipment Regulation System 14 5.2 Regulation of Electromagnetic Medical
Devices 14 5.3 Future Outlook 17 6 Pricing and Reimbursement 18
6.1 Reimbursement 18 6.2 Pricing 18 7 Distribution Structure 19 8
Ophthalmic Devices In South Africa 20 8.1 Ophthalmic Devices Cross Country
Comparison (2000-2012) 20 8.2 Ophthalmic Devices, South Africa, Overall
Revenues ($ mn), 2000-2012 21 8.3 Ophthalmic Devices, South Africa,
Category Volume (Units), 2000-2012 25 8.4 Ophthalmic Devices, South
Africa, Company Share (2006-2007) 26 9 Cataract Surgery In South Africa
27 9.1 Cataract Surgery Overall Revenue (2000-2012) 27 9.2 Cataract
Surgery Overall Volume (2000-2012) 29 9.3 Cataract Surgery Average Price
(2000-2012) 31 9.4 Cataract Surgery Distribution Share (2006-2007) 31
9.5 Cataract Surgery, South Africa, Company Share (2006-2007) 32 10
Refractive Surgery In South Africa 33 10.1 Refractive Surgery Overall
Revenue (2000-2012) 33 10.2 Refractive Surgery Overall Volume (2000-2012)
35 10.3 Refractive Surgery Average Price (2000-2012) 37 10.4
Refractive Surgery Distribution Share (2006-2007) 37 10.5 Refractive
Surgery, South Africa, Company Share (2006-2007) 38 11 Vision Care In
South Africa 39 11.1 Vision Care Overall Revenue (2000-2012) 39 11.2
Vision Care Overall Volume (2000-2012) 41 11.3 Vision Care Average Price
(2000-2012) 43 11.4 Vision Care Distribution Share (2006-2007) 44 11.5
Vision Care, South Africa, Company Share (2006-2007) 45 12 Bausch & Lomb
Incorporated Company Profile 46 12.1 Company Overview 46 12.2 Value
Chain Analysis 47 12.2.1 Manufacturing 47 12.2.2 Product Development
47 12.2.3 Sales and Marketing 49 12.3 Bausch & Lomb Incorporated
Pipeline Products 49 12.3.1 Bausch & Lomb Incorporated Pipeline Products
By Equipment Type 49 12.3.2 Bausch & Lomb Incorporated Pipeline Products
By Development Stage 49 12.3.3 Bausch & Lomb Incorporated Pipeline
Products By Therapy Area 49 12.3.4 Bausch & Lomb Incorporated Pipeline
Products By Clinical Trials 50 12.3.5 Bausch & Lomb Incorporated Pipeline
Products By News Summary 50 13 Johnson & Johnson Vision Care, Inc. Company
Profile 51 13.1 Company Overview 51 14 Alcon, Inc. Company Profile
52 14.1 Company Overview 52 14.2 Value Chain Analysis 53 14.2.1
Manufacturing 53 14.2.2 Product Development 53 14.2.3 Sales and
Marketing 55 14.3 Alcon, Inc. Pipeline Products 55 14.3.1 Alcon, Inc.
Pipeline Products By Equipment Type 55 14.3.2 Alcon, Inc. Pipeline
Products By Development Stage 56 14.3.3 Alcon, Inc. Pipeline Products By
Therapy Area 56 14.3.4 Alcon, Inc. Pipeline Products By Clinical Trials
56 14.3.5 Alcon, Inc. Pipeline Products By News Summary 56 15 Essilor
International Company Profile 57 15.1 Company Overview 57 15.2 Value
Chain Analysis 57 15.2.1 Manufacturing 58 15.2.2 Product Development
58 15.2.3 Sales and Marketing 58 16 Carl Zeiss AG Company Profile
59 16.1 Company Overview 59 16.2 Value Chain Analysis 60 16.2.1
Manufacturing 60 16.2.2 Product Development 61 16.2.3 Sales and
Marketing 61 17 CIBA Vision Corporation Company Profile 62 17.1
Company Overview 62 17.2 CIBA Vision Corporation Pipeline Products 62
17.2.1 CIBA Vision Corporation Pipeline Products By Equipment Type 62
17.2.2 CIBA Vision Corporation Pipeline Products By Development Stage 62
17.2.3 CIBA Vision Corporation Pipeline Products By Therapy Area 62 17.2.4
CIBA Vision Corporation Pipeline Products By Clinical Trials 62 18
Eurotech Optical Company Profile 63 18.1 Company Overview 63 19
APPENDIX 64 19.1 Global Markets Direct Research Methodology 64 19.2
Coverage 65 19.3 Secondary Research 65 19.4 Primary Research 66
19.5 Models 66 19.6 Forecasts 67 19.7 Expert Panels 67 19.8
Currency Conversion 68 19.9 Contact Us 69 19.10 Disclaimer 69
1.1 List of Tables Table 1: Ophthalmic Devices Cross Country
Comparison (2000-2012) 20 Table 2: Ophthalmic Devices, South Africa,
Overall Revenues ($ mn), 2000-2012 21 Table 3: Ophthalmic Devices
Market, South Africa, Portfolio Analysis, 2000-2012 22 Table 4:
Ophthalmic Devices, South Africa, Overall Revenues ($ mn), Historic, 2000-2007
23 Table 5: Ophthalmic Devices, South Africa, Overall Revenues ($
mn), Forecast, 2007-2012 24 Table 6: Ophthalmic Devices, South
Africa, Category Volume (Units), 2000-2012 25 Table 7: Ophthalmic
Devices, South Africa, Category Volume (Units), Historic, 2000-2007 25
Table 8: Ophthalmic Devices, South Africa, Category Volume (Units),
Forecast, 2007-2012 25 Table 9: Ophthalmic Devices, South Africa,
Company Share by Revenue ($ mn), 2006-2007 26 Table 10: Cataract
Surgery, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2007 27
Table 11: Cataract Surgery, South Africa, Revenue ($ mn) by Segment,
Forecast, 2007-2012 28 Table 12: Cataract Surgery, South Africa,
Overall Volume (Units), Historic, 2000-2007 29 Table 13: Cataract
Surgery, South Africa, Overall Volume (Units), Forecast, 2007-2012 30
Table 14: Cataract Surgery, South Africa, Average Price ($), Historic,
2000-2007 31 Table 15: Cataract Surgery, South Africa, Average Price
($), Forecast,, 2007-2012 31 Table 16: Cataract Surgery, South
Africa, Distribution Share by Revenue ($mn), 2006-2007 31 Table 17:
Cataract Surgery, South Africa, Company Share by Revenue ($ mn), 2006-2007
32 Table 18: Refractive Surgery, South Africa, Revenue ($ mn),
Historic, 2000-2007 33 Table 19: Refractive Surgery, South Africa,
Revenue ($ mn), Forecast, 2007-2012 34 Table 20: Refractive Surgery,
South Africa, Overall Volume (Units), Historic, 2000-2007 35 Table 21:
Refractive Surgery, South Africa, Overall Volume (Units), Forecast, 2007-2012
36 Table 22: Refractive Surgery, South Africa, Average Price ($),
Historic, 2000-2007 37 Table 23: Refractive Surgery, South Africa,
Average Price ($), Forecast,, 2007-2012 37 Table 24: Refractive
Surgery, South Africa, Distribution Share by Revenue ($mn), 2006-2007 37
Table 25: Refractive Surgery, South Africa, Company Share by Revenue ($
mn), 2006-2007 38 Table 26: Vision Care, South Africa, Revenue ($ mn)
by Segment, Historic, 2000-2007 39 Table 27: Vision Care, South
Africa, Revenue ($ mn) by Segment, Forecast, 2007-2012 40 Table 28:
Vision Care, South Africa, Overall Volume (Units), Historic, 2000-2007 41
Table 29: Vision Care, South Africa, Overall Volume (Units), Forecast,
2007-2012 42 Table 30: Vision Care, South Africa, Average Price ($),
Historic, 2000-2007 43 Table 31: Vision Care, South Africa, Average
Price ($), Forecast,, 2007-2012 43 Table 32: Vision Care, South
Africa, Distribution Share by Revenue ($mn), 2006-2007 44 Table 33:
Vision Care, South Africa, Company Share by Revenue ($ mn), 2006-2007 45
Table 34: Bausch & Lomb Incorporated Pipeline Products by Equipment Type
49 Table 35: Bausch & Lomb Incorporated Pipeline Products By
Development Stage 49 Table 36: Bausch & Lomb Incorporated Pipeline
Products By Therapy Area 49 Table 37: Bausch & Lomb Incorporated
Pipeline Products By Clinical Trials 50 Table 38: Bausch & Lomb
Incorporated Pipeline Products By News Summaries 50 Table 39: Alcon,
Inc. Pipeline Products by Equipment Type 55 Table 40: Alcon, Inc.
Pipeline Products By Development Stage 56 Table 41: Alcon, Inc.
Pipeline Products By Therapy Area 56 Table 42: Alcon, Inc. Pipeline
Products By Clinical Trials 56 Table 43: Alcon, Inc. Pipeline
Products By News Summaries 56 Table 44: CIBA Vision Corporation
Pipeline Products by Equipment Type 62 Table 45: CIBA Vision
Corporation Pipeline Products by Development Stage 62 Table 46: CIBA
Vision Corporation Pipeline Products By Therapy Area 62 Table 47:
CIBA Vision Corporation Pipeline Products By Clinical Trials 62 Table 48:
Currency Conversion from USD to Local Currency at 2007 Constant Rate 68
1.2 List of Figures Figure 1: Ophthalmic Devices Cross Country
Comparison (2000-2012) 20 Figure 2: Ophthalmic Devices, South Africa,
Overall Revenues ($ mn), 2000-2012 21 Figure 3: Ophthalmic Devices Market,
South Africa, Portfolio Analysis, 2000-2012 22 Figure 4: Ophthalmic
Devices, South Africa, Overall Revenues ($ mn), Historic, 2000-2007 23
Figure 5: Ophthalmic Devices, South Africa, Overall Revenues ($ mn),
Forecast, 2007-2012 24 Figure 6: Ophthalmic Devices, South Africa,
Company Share (%), 2007 26 Figure 7: Cataract Surgery, South Africa,
Revenue ($ mn) by Segment, Historic, 2000-2007 27 Figure 8: Cataract
Surgery, South Africa, Revenue ($ mn) by Segment, Forecast, 2007-2012 28
Figure 9: Cataract Surgery, South Africa, Overall Volume (Units),
Historic, 2000-2007 29 Figure 10: Cataract Surgery, South Africa,
Overall Volume (Units), Forecast, 2007-2012 30 Figure 11: Cataract
Surgery, South Africa, Company Share (%), 2007 32 Figure 12:
Refractive Surgery, South Africa, Revenue ($ mn), Historic, 2000-2007 33
Figure 13: Refractive Surgery, South Africa, Revenue ($ mn), Forecast,
2007-2012 34 Figure 14: Refractive Surgery, South Africa, Overall
Volume (Units), Historic, 2000-2007 35 Figure 15: Refractive Surgery,
South Africa, Overall Volume (Units), Forecast, 2007-2012 36 Figure 16:
Refractive Surgery, South Africa, Company Share (%), 2007 38 Figure 17:
Vision Care, South Africa, Revenue ($ mn) by Segment, Historic, 2000-2007
39 Figure 18: Vision Care, South Africa, Revenue ($ mn) by Segment,
Forecast, 2007-2012 40 Figure 19: Vision Care, South Africa, Overall
Volume (Units), Historic, 2000-2007 41 Figure 20: Vision Care, South
Africa, Overall Volume (Units), Forecast, 2007-2012 42 Figure 21:
Vision Care, South Africa, Company Share (%), 2007 45 Figure 22:
Bausch & Lomb Incorporated Value Chain Analysis 47 Figure 23: Alcon,
Inc. Value Chain Analysis 53 Figure 24: Essilor International Value
Chain Analysis 57 Figure 25: Carl Zeiss AG Value Chain Analysis
60 Figure 26: Global Markets Direct Methodology 64
|
Related Report
|